In a finding that could have important implications for the millions of Americans who suffer from asthma, researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID) have discovered novel sets of genes possibly involved in the disease. Their study has also revealed what the scientists believe is a key role for the enzyme arginase in causing asthmatic symptoms. The research, led by Marc E. Rothenberg, M.D., Ph.D., of Cincinnati Children’s Hospital Medical Center, opens the possibility of developing new anti-asthma drugs to block arginase activity.
For more information, go to: National Institute of Allergy and Infectious Diseases (NIAID)
NIAID Office of Communications and Public Liaison
Message posted by: Rashmi Nemade
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...